Home > Rheumatology > Worse AMI outcomes for lupus, systemic sclerosis patients

Worse AMI outcomes for lupus, systemic sclerosis patients


Notice: Undefined index: new_doi_fields in /home/daan/projects/medicalconferences_dev/wp-content/themes/writers-blogily-child/template-parts/content-structured.php on line 22

Notice: Trying to access array offset on value of type null in /home/daan/projects/medicalconferences_dev/wp-content/themes/writers-blogily-child/template-parts/content-structured.php on line 22

Notice: Trying to access array offset on value of type null in /home/daan/projects/medicalconferences_dev/wp-content/themes/writers-blogily-child/template-parts/content-structured.php on line 22
Journal
Mayo Clinic Proceedings
Reuters Health - 15/12/2020 -Patients with systemic lupus erythematosus (SLE) are less likely to receive invasive treatment for acute myocardial infarction (AMI) and have worse AMI outcomes than do patients without autoimmune rheumatic disease (AIRD), new research shows. Rheumatoid arthritis (RA) and systemic sclerosis (SSC) patients weren't less likely to get invasive management than patients without AIRD, but like SLE patients, those with SSC were had higher mortality, Dr. Mamas Mamas and colleagues of Keele University, in Stoke-on-Trent, U.K., found. "These are three very different populations with very different outcomes and risk factor profiles," Dr. Mamas told Reuters Health by phone. "We should be thinking of these rheumatic diseases as individual disorders." AIRD is associated with an increased AMI risk, but it has not been clear if outcomes vary by disease subtype, Dr. Mamas and his team note in Mayo Clinic Proceedings. To investigate, they looked at...


Please login to read the full text of the article.


If you have no account yet, please register now.





Posted on